{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:17:49Z","timestamp":1791940669903,"version":"4.3.4"},"reference-count":28,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["P3-0323"],"award-info":[{"award-number":["P3-0323"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) can lead to various multisystem disorders, including thrombotic microangiopathy (TMA). We present here eight patients with COVID-19-associated TMA who were treated at our center. Our aim was to summarize the demographic and clinical characteristics of the patients and discuss the possible role of COVID-19. One patient presented with thrombotic thrombocytopenic purpura (TTP) and seven with atypical hemolytic\u2013uremic syndrome (aHUS.) Most patients had no obvious symptoms of COVID-19, and TMA occurred after viremia. Two patients had concomitant non-COVID-19-related triggers for TMA: exposure to tacrolimus and everolimus; first presentation of antiphospholipid syndrome. The patient with TTP was treated with therapeutic plasma exchange (TPE), steroids and caplacizumab, resulting in complete hematologic recovery. Six patients with aHUS were treated with TPE with or without steroids, four of whom received a C5 complement inhibitor and one an intravenous immunoglobulin. One patient with aHUS was treated with a C5 complement inhibitor and a steroid. We observed one partial and one complete recovery of renal function, while five patients experienced renal failure. There were no deaths. We believe that COVID-19 may act as a trigger for TMA in patients who have either pre-existing endothelial injury or an underlying predisposition to complement activation, and may also trigger autoimmune diseases. As a consequence of the different underlying pathophysiologies, the treatment of COVID-19-associated TMA requires a specific approach based on the subtype of the syndrome and possible concomitant triggers.<\/jats:p>","DOI":"10.3390\/ijms252212475","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:46:11Z","timestamp":1732164371000},"page":"12475","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: A Single-Center Experience"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-9441","authenticated-orcid":false,"given":"Marija","family":"Malgaj Vre\u010dko","sequence":"first","affiliation":[{"name":"Department of Nephrology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreja","family":"Ale\u0161-Rigler","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160pela","family":"Bor\u0161tnar","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljka","family":"Ve\u010deri\u0107-Haler","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","article-title":"Acute kidney injury in patients hospitalized with COVID-19","volume":"98","author":"Hirsch","year":"2020","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1681\/ASN.2020050699","article-title":"COVID-19\u2013Associated Kidney Injury: A Case Series of Kidney Biopsy Findings","volume":"31","author":"Sharma","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5500\/wjt.v11.i11.480","article-title":"Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review","volume":"11","author":"Jeyalan","year":"2021","journal-title":"World J. Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.thromres.2021.04.012","article-title":"COVID-19 and thrombotic microangiopathies","volume":"202","author":"Tiwari","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of Thrombotic Microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: Conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic Microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41584-020-0474-5","article-title":"Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications","volume":"16","author":"Merrill","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Vre\u010dko, M.M., Rigler, A.A., and Ve\u010deri\u0107-Haler, \u017d. (2022). Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911307"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.14740\/jh1019","article-title":"Coronavirus Disease 2019-Associated Thrombotic Microangiopathy","volume":"11","author":"Vrecko","year":"2022","journal-title":"J. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"151436","DOI":"10.1016\/j.semnephrol.2023.151436","article-title":"HUS and TTP: Traversing the disease and the age spectrum","volume":"43","author":"Donadelli","year":"2023","journal-title":"Semin. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood.2021012752","article-title":"COVID-19 as a potential trigger of complement-mediated atypical HUS","volume":"138","author":"Saldman","year":"2021","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.ekir.2023.05.010","article-title":"Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination","volume":"8","author":"Aigner","year":"2023","journal-title":"Kidney Int. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00277-020-04097-0","article-title":"Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19","volume":"99","author":"Albiol","year":"2020","journal-title":"Ann. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Boudhabhay, I., Rabant, M., Roumenina, L.T., Coupry, L.-M., Poillerat, V., Marchal, A., Fr\u00e9meaux-Bacchi, V., El Karoui, K., Monchi, M., and Pourcine, F. (2021). Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.680567"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tarasewicz, A., Perkowska-Ptasi\u0144ska, A., and D\u0119bska-\u015alizie\u0144, A. (2021). Thrombotic microangiopathy in a kidney transplant patient after COVID-19. Pol. Arch. Intern. Med., 131.","DOI":"10.20452\/pamw.16125"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5414\/CN111217","article-title":"Post-COVID-19 complement-mediated TMA: A case report","volume":"102","author":"Jochims","year":"2024","journal-title":"Clin. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2215\/CJN.11470918","article-title":"Etiology and Outcomes of Thrombotic Microangiopathies","volume":"14","author":"Bayer","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"103206","DOI":"10.1016\/j.autrev.2022.103206","article-title":"COVID-19 and the antiphospholipid syndrome","volume":"21","author":"Serrano","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Borghi, M.O., Beltagy, A., Garrafa, E., Curreli, D., Cecchini, G., Bodio, C., Grossi, C., Blengino, S., Tincani, A., and Franceschini, F. (2020). Anti-Phospholipid Antibodies in COVID-19 Are Different from Those Detectable in the Anti-Phospholipid Syndrome. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.584241"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/ard.62.5.388","article-title":"Antiphospholipid antibodies and infections","volume":"62","author":"Asherson","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","first-page":"097","article-title":"\u201cTrue\u201d Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies","volume":"49","author":"Arcani","year":"2022","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sinkovits, G., Mez\u0151, B., R\u00e9ti, M., M\u00fcller, V., Iv\u00e1nyi, Z., G\u00e1l, J., Gopcsa, L., Rem\u00e9nyi, P., Szathm\u00e1ry, B., and Lakatos, B. (2021). Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.663187"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00281-021-00882-9","article-title":"Complement activation in IgA nephropathy","volume":"43","author":"Cook","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Menne, J., Delmas, Y., Fakhouri, F., Licht, C., Lommel\u00e9, \u00c5., Minetti, E.E., Prov\u00f4t, F., Rondeau, E., Sheerin, N.S., and Wang, J. (2019). Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1314-1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","article-title":"The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: All patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency","volume":"3","author":"Terrell","year":"2005","journal-title":"J. Thromb. Haemost."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12475\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:36:17Z","timestamp":1760114177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":28,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252212475"],"URL":"https:\/\/doi.org\/10.3390\/ijms252212475","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}